ClinicalTrials.Veeva

Menu

Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects

W

Wecare Probiotics

Status

Completed

Conditions

Overweight or Obesity

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Probiotic

Study type

Interventional

Funder types

Industry

Identifiers

NCT06653101
WK2024014

Details and patient eligibility

About

To assess the efficacy and safety of the use of probiotics as a food supplement compared to placebo in regulating body metabolism and gut microbiota in overweight or obese subjects.

Enrollment

110 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. 18-45 years old;
  2. BMI ≥ 24 kg/m2 or men with a body fat percentage of ≥ 25% and women with a body fat percentage of ≥ 30%;
  3. Normal liver function indexes;
  4. Willing to complete study-related questionnaires and diaries and complete all clinical visits.

Exclusion criteria

  1. Those who have been diagnosed with high uric acid or gout are not recommended to participate in the test;
  2. Psychiatric or neurological diseases, celiac disease, lactose intolerance, allergies;
  3. Have the following diseases: irritable bowel syndrome, ulcerative colitis, fatty liver, liver cirrhosis, etc.;
  4. Recently treated with antibiotics (i.e., < 3 months prior to the start of the study);
  5. Participants who smoked more than 10 cigarettes per day were excluded;
  6. It is not recommended to participate in other special circumstances, such as those who are allergic to probiotic products;
  7. Pregnant and lactating women are not suitable for experiments.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

110 participants in 2 patient groups, including a placebo group

Probiotic group
Experimental group
Description:
Akk11 capsule, 30 billion AFU/day, before meals
Treatment:
Dietary Supplement: Probiotic
Placebo group
Placebo Comparator group
Description:
Placebo capsule, three capsules/day, before meals
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems